Shilpa Medicare

Shilpa Medicare, founded in 1987, is a prominent player in the pharmaceutical and healthcare sectors. The company specializes in the manufacturing and distribution of active pharmaceutical ingredients (APIs), intermediates, and advanced formulations. With a robust global footprint, Shilpa Medicare serves markets across India, the United States, and Europe, providing critical oncology and non-oncology solutions. Their diverse product portfolio includes specialty chemicals, peptides, and innovative biotech products, positioning them as a key contributor to global health infrastructure.

Operating with a workforce of 1,000-5,000 employees, the company maintains a sophisticated operational structure across two primary locations. Their technical capabilities extend to contract manufacturing, offering a wide range of dosage forms such as tablets, capsules, liquid injections, and sterile dry powder injectables. Meet Shilpa Medicare's team to understand the expertise driving these complex manufacturing processes. The organization also integrates sustainable practices into its business model, including active involvement in wind power generation, which complements its core pharmaceutical manufacturing operations.

Shilpa Medicare continues to leverage its extensive research and development capabilities to advance new drug delivery systems. By focusing on specialty generic pharmaceuticals and high-quality ingredients, the firm maintains a competitive edge in the B2B and B2C markets. The company’s commitment to quality and regulatory compliance supports its long-term growth strategy within the international healthcare landscape. With a revenue of $137.7M, Shilpa Medicare remains dedicated to delivering high-value medical solutions while expanding its reach through strategic manufacturing partnerships and technological innovation in the pharmaceutical sector.